Osimertinib in Untreated <i>EGFR</i> -Mutated Advanced Non–Small-Cell Lung Cancer
2017 · New England Journal of Medicine · 5,025 citations
https://doi.org/10.1056/nejmoa1713137
T
Thanyanan Reungwetwattana
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
136
Papers
11.8K
Citations
30
h-index
48
i10-index
Thanyanan Reungwetwattana is an academic researcher from Mahidol University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Diagnosis and Treatment & Lung Cancer Research Studies. The author has an h-index of 30, co-authored 116 publications.
ORCID: 0000-0002-3147-7640Papers by this author
worksAdjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis
2019 · Expert Review of Clinical Pharmacology · 49 citations
https://doi.org/10.1080/17512433.2019.1637252
Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group
2023 · ESMO Open · 36 citations
https://doi.org/10.1016/j.esmoop.2023.101586
Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy
2020 · Scientific Reports · 35 citations
https://doi.org/10.1038/s41598-020-70351-0
Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines
2019 · BMC Health Services Research · 32 citations
https://doi.org/10.1186/s12913-019-4715-8
Preloading magnesium attenuates cisplatin-associated nephrotoxicity: pilot randomized controlled trial (PRAGMATIC study)
2021 · ESMO Open · 23 citations
https://doi.org/10.1016/j.esmoop.2021.100351
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat